| (210) | Number of the EPO application | 22180767 |
| (220) | Filing date of the EPO application | 2017.12.14 |
| (80) | EPO patent specification publication (B) | EPB nr. 15/2024, 2024.04.10 |
| (110) | EPO patent number | 4122497 |
| (11) | Number of the document | MD 4122497 T2 |
| (21) | Number of the application | e 2023 0818 |
| (71) | Name(s) of applicant(s), code of the country | SAREPTA THERAPEUTICS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | PASSINI Marco A., US;
HANSON Gunnar J., US; |
| (73) | Name(s) of owner(s), code of the country | SAREPTA THERAPEUTICS, INC., US; |
| (54) | Title of the invention | Exon skipping oligomer conjugates for muscular dystrophy |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 47/64 (2017.01.01); A61P 21/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2023.09.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.09.30 |
| (30) | Priority | 201662436199 P, 2016.12.19, US; 201762443481 P, 2017.01.06, US; 201762479177 P, 2017.03.30, US; 201762562119 P, 2017.09.22, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |